Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries VBI Vaccines, Inc. - Ordinary Shares (NQ: VBIV ) 0.0653 UNCHANGED Last Price Updated: 4:00 PM EDT, Aug 7, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about VBI Vaccines, Inc. - Ordinary Shares < Previous 1 2 3 4 5 6 7 Next > Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday August 07, 2024 Pre-market stock movers are a hot topic on Wednesday and we have all of the latest news traders need to know about them this morning! Via InvestorPlace Why Fortinet Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket August 07, 2024 Via Benzinga Dow Jumps Over 300 Points; US Trade Gap Narrows In June August 06, 2024 Via Benzinga Topics Stocks Exposures US Equities Why Is VBI Vaccines (VBIV) Stock Up 62% Today? August 06, 2024 VBI Vaccines stock is up on Tuesday as shares of VBIV continue to be volatile after the company filed for bankruptcy last week. Via InvestorPlace Topics Bankruptcy Exposures Financial Legal Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday August 06, 2024 We have all of the biggest pre-market stock movers that traders are going to want to read about on Tuesday! Via InvestorPlace S&P 500 Down Over 100 Points; Actinium Pharmaceuticals Shares Plunge August 05, 2024 Via Benzinga Topics Stocks Exposures US Equities Dow Tumbles 950 Points; ISM Services PMI Surges In July August 05, 2024 Via Benzinga Topics Stocks Exposures US Equities Nasdaq Tumbles 3%; Tyson Foods Earnings Top Views August 05, 2024 Via Benzinga VBI Vaccines Provides an Update on its Restructuring Proceedings August 02, 2024 From VBI Vaccines Inc. Via Business Wire Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session July 30, 2024 Via Benzinga VBI Vaccines Initiates Restructuring Proceedings Under CCAA to Implement a Review of its Strategic Alternatives July 30, 2024 From VBI Vaccines Inc. Via Business Wire VBI Vaccines Announces Results of Annual General Meeting June 25, 2024 From VBI Vaccines Inc. Via Business Wire VBI Vaccines Announces New Tumor Response Data from Ongoing Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma Patients May 29, 2024 From VBI Vaccines Inc. Via Business Wire VBI Vaccines Announces Poster Presentation at 2024 ASCO Annual Meeting Highlighting New Interim Phase 2b Data from VBI-1901 in Recurrent Glioblastoma Patients May 22, 2024 From VBI Vaccines Inc. Via Business Wire VBIV Stock Earnings: VBI Vaccines Misses EPS, Misses Revenue for Q1 2024 May 15, 2024 VBIV stock results show that VBI Vaccines missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. Via InvestorPlace VBI Vaccines Reports First Quarter 2024 Financial Results May 15, 2024 From VBI Vaccines Inc. Via Business Wire VBIV Stock Earnings: VBI Vaccines Beats EPS, Misses Revenue for Q4 2023 April 16, 2024 VBIV stock results show that VBI Vaccines beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023. Via InvestorPlace VBI Vaccines Reports Full Year 2023 Financial Results April 16, 2024 From VBI Vaccines Inc. Via Business Wire VBI Vaccines Announces Closing of $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules April 11, 2024 From VBI Vaccines Inc. Via Business Wire Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session April 11, 2024 Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results. Via Benzinga VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules April 09, 2024 From VBI Vaccines Inc. Via Business Wire Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket April 09, 2024 Shares of Biophytis S.A. (NASDAQ: BPTS) rose sharply in today’s pre-market trading after reporting FY23 results. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday April 05, 2024 It's time to dive into all of the biggest pre-market stock movers that traders will want to keep an eye on Friday morning! Via InvestorPlace VBI Vaccines Presents Encouraging Early Tumor Response Data From Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma April 03, 2024 From VBI Vaccines Inc. Via Business Wire VBI Vaccines Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA-Launched eVLP (MLE) Vaccine Platform April 02, 2024 From VBI Vaccines Inc. Via Business Wire Why Robinhood Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket February 14, 2024 Shares of Robinhood Markets, Inc. (NASDAQ: HOOD) shares rose sharply in today’s pre-market trading after the company reported better-than-expected fourth- Via Benzinga Why Sony Shares Are Trading Lower By Around 6%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session February 14, 2024 Shares of Sony Group Corporation (NYSE: SONY) fell during Wednesday’s session after the company reported third-quarter financial results and revised guidance above estimates and shared plans to list... Via Benzinga VBI Announces Agreement to Sell Manufacturing Capabilities, Certain Related Assets, and Enter Into New License Agreement with Brii Biosciences February 14, 2024 From VBI Vaccines Inc. Via Business Wire Why Faraday Future Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket November 24, 2023 Shares of Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE) surged in pre-market trading after the company announced its foray into the Middle Ea Via Benzinga VBI Vaccines Presents Additional Biomarker Data from Phase 1/2a Study of VBI-1901 in Recurrent GBM at the 2023 Society for Neuro-Oncology (SNO) Annual Meeting November 20, 2023 From VBI Vaccines Inc. Via Business Wire < Previous 1 2 3 4 5 6 7 Next > Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
